高危结直肠癌肝转移切除术后健康相关生活质量的纵向前瞻性研究
这项前瞻性研究纳入临床风险评分≥3的可切除结直肠癌肝转移患者,在术前、术后及术后6至36个月使用EORTC QLQ-C30、LMC21和EQ-5D-5L评估健康相关生活质量。结果显示QLQ-C30汇总评分术后较基线下降14.6分,12个月恢复至术前水平;无疾病证据患者6个月恢复基线,而复发患者各随访点均低于基线。
要点
- 高危CRLM肝切除术后QLQ-C30汇总评分下降14.6分,12个月恢复术前水平。
- 无疾病证据患者6个月恢复基线,24个月EQ-VAS高于基线。
- 癌症复发显著影响生活质量,复发患者各随访点低于无疾病证据患者。
核心结论
- 肝切除术后健康相关生活质量下降,随后恢复至术前水平,无复发患者甚至超过基线。
- 癌症复发显著影响健康相关生活质量。
研究设计与样本
- 前瞻性研究,纳入临床风险评分≥3的可切除结直肠癌肝转移患者,297例同意,146例完成术前和术后调查可评估。
- 中位年龄52岁,42%(n=61)为女性,70%(n=102)为同时性结直肠癌肝转移。
- 使用EORTC QLQ-C30、LMC21和EuroQol EQ-5D-5L在术前、术后及术后6、12、18、24、36个月评估,并记录癌症疾病状态。
- 采用线性混合模型分析健康相关生活质量评分轨迹。
主要发现
- QLQ-C30汇总评分术后调查较基线下降-14.6分(95% CI:-17.2,-12.0),P<0.001,12个月恢复至术前水平。
- EQ-VAS自评健康状态术后较基线下降-8.9分(95% CI:-12.2,-5.5),P<0.001,6个月恢复至基线。
- 无疾病证据患者QLQ-C30汇总评分在肝切除术后6个月恢复至术前水平;复发患者各随访评估评分均低于基线(所有P<0.05)。
- 无疾病证据患者EQ-VAS在6个月与基线相当,24个月评分高于基线(P=0.029);复发患者12个月EQ-VAS与基线相似,但术后调查后各时间点均低于无疾病证据患者(所有P<0.05)。
临床怎么用
- 高危CRLM肝切除术后应关注生活质量下降,多数患者12个月内恢复,但复发患者持续受损。
- 术后随访中可将生活质量评估纳入监测,尤其对复发患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Describe the long-term health-related quality of life (HR-QoL) after curative-intent hepatectomy for high-risk colorectal liver metastases (CRLM). METHODS: This prospective study enrolled patients with resectable CRLM with clinical risk score ≥3. European Organization for Research and Treatment of Cancer QLQ-C30, LMC21, and EuroQol EQ-5D-5L were administered at preoperative and postoperative visits, and at 6, 12, 18, 24, and 36 months from hepatectomy, and cancer disease state was recorded. Linear mixed models were used to examine the trajectory of HR-QoL scores. RESULTS: From 297 consented, 146 were evaluable by completing preoperative and postoperative surveys. Median age was 52 years, 42% (n=61) were female, and 70% (n=102) had synchronous CRLM. The QLQ-C30 summary score decreased by -14.6 points (95% CI: -17.2, -12.0) from baseline at the postoperative survey (P<0.001) with return to preoperative levels at 12 months. Self-assessed health state on EQ-VAS decreased postoperatively by -8.9 points (95% CI: -12.2, -5.5) (P<0.001) with recovery to baseline by 6 months. Among patients with no evidence of disease (NED), QLQ-C30 summary scores recovered to preoperative levels 6 months after hepatectomy, whereas those with recurrent cancer reported scores below baseline at every follow-up assessment (all P<0.05). On EQ-VAS, NED patients were comparable to baseline at 6 months and reported higher scores than baseline at 24 months (P=0.029). Patients with recurrence had similar EQ-VAS scores as baseline at 12 months but remained lower than NED patients at each timepoint after the postoperative survey (all P<0.05). CONCLUSIONS: HR-QoL decreases postoperatively before returning to preoperative levels and exceeding it among patients without recurrence. Cancer recurrence significantly influenced HR-QoL.
引用
- Choubey AP, Leal J, White C, et al. Beyond Survival: Prospective Longitudinal Insights into Health-related Quality of Life After Hepatectomy for High-risk Colorectal Liver Metastases. Ann Surg. 2026. PMID: 42572133. doi:10.1097/SLA.0000000000007165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。